Harbour Investments’s NovoCure NVCR Stock Holding History

Harbour Investments’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.89K	Hold	265	–	–	﹤0.01%	3789
2025 Q4	$3.43K	Buy	265 +116	+78%	+$1.49K	﹤0.01%	3154
2025 Q3	$1.93K	Buy	+149	New	+$1.99K	﹤0.01%	3285
2023 Q4	–	Sell	-47	Closed	-$759	–	3164
2023 Q3	$759	Hold	47	–	–	﹤0.01%	2748
2023 Q2	$1.95K	Sell	47 -100	-68%	-$6.21K	﹤0.01%	2548
2023 Q1	$8.84K	Sell	147 -3	-2%	-$240	﹤0.01%	2068
2022 Q4	$11K	Buy	150 +4	+3%	+$301	﹤0.01%	1924
2022 Q3	$10K	Hold	146	–	–	﹤0.01%	1932
2022 Q2	$10K	Buy	+146	New	+$11K	﹤0.01%	1932
2021 Q4	$11K	Sell	146 -434	-75%	-$43.6K	﹤0.01%	1895
2021 Q3	$67K	Buy	580 +33	+6%	+$4.99K	﹤0.01%	1596
2021 Q2	$121K	Buy	547 +80	+17%	+$15.6K	﹤0.01%	1300
2021 Q1	$62K	Buy	+467	New	+$73.9K	﹤0.01%	1554

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Harbour Investments's NVCR Position: Q1 2026 in Review

Harbour Investments held its NovoCure (NVCR) position steady in Q1 2026 at 265 shares worth $2.89K. The position accounts for ﹤0.01% of the portfolio, ranked #3789.

Harbour Investments first reported a position in NVCR in Q1 2021 and has held it in 13 quarters since. The position peaked at $121K in Q2 2021. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

Harbour Investments held 265 shares of NovoCure worth $2.89K as of Q1 2026.
Harbour Investments left its NovoCure share count unchanged in Q1 2026.
NovoCure made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #3789 holding.
Harbour Investments first reported a position in NovoCure in Q1 2021 and has held it in 13 quarters since.
Harbour Investments's NovoCure position peaked at $121K in Q2 2021.
222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.